{"entity":{"type":"insider","cik":"0001270905","url":"/insider/0001270905","json_url":"/insider/0001270905.json","name":"Eansor Norman David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":12,"first":"2003-12-23","last":"2023-06-08","span_basis":"filed_date"},"name_variants":[{"name":"Eansor Norman David","source":"filing","n_filings":9,"first_seen":"2018-05-11","last_seen":"2023-06-08"},{"name":"EANSOR N DAVID","source":"filing","n_filings":3,"first_seen":"2003-12-23","last_seen":"2006-01-06"}],"transactions":[{"id":5277404,"accession":"0000914190-21-000405","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000914190-21-000405","line_url":"/filing/0000914190-21-000405","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27159.0,"shares_display":"27,159","price_per_share":504.00209669722744,"price_display":"504.00","price_state":"stated","total_value":13688192.9442,"total_display":"13,688,192.94","total_whole":"13,688,193","shares_owned_after":13243.0,"shares_owned_after_display":"13,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-16","scope":"insider","n_lines":10},{"id":4510678,"accession":"0000914190-21-000322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914190-21-000322","line_url":"/filing/0000914190-21-000322#line-1","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1538.0,"shares_display":"1,538","price_per_share":503.0739,"price_display":"503.07","price_state":"stated","total_value":773727.6582,"total_display":"773,727.66","total_whole":"773,728","shares_owned_after":1318.0,"shares_owned_after_display":"1,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-09-02","scope":"insider"},{"id":8188361,"accession":"0001209191-23-035617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035617","line_url":"/filing/0001209191-23-035617#line-1","is_derivative":false,"issuer_cik":"0001094038","issuer_name":"Marker Therapeutics, Inc.","issuer_ticker":"MRKR","issuer_name_source":null,"issuer_url":"/issuer/0001094038","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14285.0,"shares_display":"14,285","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":249987.5,"total_display":"249,987.50","total_whole":"249,988","shares_owned_after":16713.0,"shares_owned_after_display":"16,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2023-06-08","scope":"insider"},{"id":4930770,"accession":"0000914190-21-000037","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000914190-21-000037","line_url":"/filing/0000914190-21-000037","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32933.0,"shares_display":"32,933","price_per_share":380.682686393587,"price_display":"380.68","price_state":"stated","total_value":12537022.911,"total_display":"12,537,022.91","total_whole":"12,537,023","shares_owned_after":10918.0,"shares_owned_after_display":"10,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider","n_lines":7},{"id":2134642,"accession":"0000914190-20-000195","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000914190-20-000195","line_url":"/filing/0000914190-20-000195","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7909.0,"shares_display":"7,909","price_per_share":261.99772500948285,"price_display":"262.00","price_state":"stated","total_value":2072140.0071,"total_display":"2,072,140.01","total_whole":"2,072,140","shares_owned_after":2809.0,"shares_owned_after_display":"2,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-29","filed_date":"2020-06-01","scope":"insider","n_lines":4},{"id":2134626,"accession":"0000914190-20-000195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914190-20-000195","line_url":"/filing/0000914190-20-000195#line-2","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3448.0,"shares_display":"3,448","price_per_share":260.1897,"price_display":"260.19","price_state":"stated","total_value":897134.0856,"total_display":"897,134.09","total_whole":"897,134","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-06-01","scope":"insider"},{"id":2134620,"accession":"0000914190-20-000183","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000914190-20-000183","line_url":"/filing/0000914190-20-000183","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12600.0,"shares_display":"12,600","price_per_share":267.9306006349206,"price_display":"267.93","price_state":"stated","total_value":3375925.568,"total_display":"3,375,925.57","total_whole":"3,375,926","shares_owned_after":4924.0,"shares_owned_after_display":"4,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-26","scope":"insider","n_lines":2},{"id":2134608,"accession":"0000914190-20-000183","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000914190-20-000183","line_url":"/filing/0000914190-20-000183","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11037.0,"shares_display":"11,037","price_per_share":267.4926205490622,"price_display":"267.49","price_state":"stated","total_value":2952316.053,"total_display":"2,952,316.05","total_whole":"2,952,316","shares_owned_after":900.0,"shares_owned_after_display":"900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-26","scope":"insider","n_lines":2},{"id":2992908,"accession":"0000914190-20-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914190-20-000109","line_url":"/filing/0000914190-20-000109#line-1","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (President-Protein Sciences)","role_mark":"O","role_mark_label":"Officer (President-Protein Sciences)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President-Protein Sciences","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1387.0,"shares_display":"1,387","price_per_share":198.68,"price_display":"198.68","price_state":"stated","total_value":275569.16,"total_display":"275,569.16","total_whole":"275,569","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-06","scope":"insider"},{"id":8534671,"accession":"0001562180-19-003526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-003526","line_url":"/filing/0001562180-19-003526#line-1","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (SVP - Novus Biologicals)","role_mark":"O","role_mark_label":"Officer (SVP - Novus Biologicals)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP - Novus Biologicals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3117.0,"shares_display":"3,117","price_per_share":215.0,"price_display":"215.00","price_state":"stated","total_value":670155.0,"total_display":"670,155.00","total_whole":"670,155","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-14","scope":"insider"},{"id":6448851,"accession":"0001562180-18-002455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-18-002455","line_url":"/filing/0001562180-18-002455#line-1","is_derivative":false,"issuer_cik":"0000842023","issuer_name":"BIO-TECHNE Corp","issuer_ticker":"TECH","issuer_name_source":null,"issuer_url":"/issuer/0000842023","owner_cik":"0001270905","owner_name":"Eansor Norman David","owner_display_name":"Eansor Norman David","owner_url":"/insider/0001270905","role":"Officer (SVP - Novus Biologicals)","role_mark":"O","role_mark_label":"Officer (SVP - Novus Biologicals)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP - Novus Biologicals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1136.0,"shares_display":"1,136","price_per_share":145.1864,"price_display":"145.19","price_state":"stated","total_value":164931.7504,"total_display":"164,931.75","total_whole":"164,932","shares_owned_after":2266.0,"shares_owned_after_display":"2,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-04","filed_date":"2018-05-11","scope":"insider"},{"id":5526315,"accession":"0000820081-06-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000820081-06-000001","line_url":"/filing/0000820081-06-000001#line-1","is_derivative":false,"issuer_cik":"0000820081","issuer_name":"CAMBREX CORP","issuer_ticker":"CBM","issuer_name_source":null,"issuer_url":"/issuer/0000820081","owner_cik":"0001270905","owner_name":"EANSOR N DAVID","owner_display_name":"EANSOR N DAVID","owner_url":"/insider/0001270905","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1439.0,"shares_display":"1,439","price_per_share":20.49,"price_display":"20.49","price_state":"stated","total_value":29485.11,"total_display":"29,485.11","total_whole":"29,485","shares_owned_after":6298.0,"shares_owned_after_display":"6,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-06","filed_date":"2006-01-06","scope":"insider"},{"id":256336,"accession":"0001270905-04-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001270905-04-000002","line_url":"/filing/0001270905-04-000002","is_derivative":false,"issuer_cik":"0000820081","issuer_name":"CAMBREX CORP","issuer_ticker":"CBM","issuer_name_source":null,"issuer_url":"/issuer/0000820081","owner_cik":"0001270905","owner_name":"EANSOR N DAVID","owner_display_name":"EANSOR N DAVID","owner_url":"/insider/0001270905","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":25.918082191780822,"price_display":"25.92","price_state":"stated","total_value":189202.0,"total_display":"189,202.00","total_whole":"189,202","shares_owned_after":3906.0,"shares_owned_after_display":"3,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-03-17","filed_date":"2004-03-19","scope":"insider","n_lines":2},{"id":69796,"accession":"0001270905-03-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001270905-03-000007","line_url":"/filing/0001270905-03-000007#line-1","is_derivative":false,"issuer_cik":"0000820081","issuer_name":"CAMBREX CORP","issuer_ticker":"CBM","issuer_name_source":null,"issuer_url":"/issuer/0000820081","owner_cik":"0001270905","owner_name":"EANSOR N DAVID","owner_display_name":"EANSOR N DAVID","owner_url":"/insider/0001270905","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":25.3,"price_display":"25.30","price_state":"stated","total_value":80960.0,"total_display":"80,960.00","total_whole":"80,960","shares_owned_after":7300.0,"shares_owned_after_display":"7,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-12-23","filed_date":"2003-12-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001094038","name":"Marker Therapeutics, Inc.","url":"/issuer/0001094038","role":"Director","n_filings":1,"first_seen":"2023-06-08","last_seen":"2023-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000842023","name":"BIO-TECHNE Corp","url":"/issuer/0000842023","role":"Officer (President-Protein Sciences)","n_filings":8,"first_seen":"2018-05-11","last_seen":"2021-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000820081","name":"CAMBREX CORP","url":"/issuer/0000820081","role":"Other","n_filings":3,"first_seen":"2003-12-23","last_seen":"2006-01-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001270905","retrieved_at":"2026-08-23T23:12:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}